Takeru Wakabayashi

Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts

Tomoaki Nakata, K Miyamoto, Atsushi Doi et al. · Journal of Nuclear Cardiology · 1998 · 188 citations

Cardiomyopathy, Heart Failure, Cardiovascular Disease +11

Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.

Takeru Wakabayashi, Tomoaki Nakata, Akiyoshi Hashimoto et al. · PubMed · 2001 · 161 citations

Predicting the Need for an Implantable Cardioverter Defibrillator Using Cardiac Metaiodobenzylguanidine Activity Together with Plasma Natriuretic Peptide Concentration or Left Ventricular Function

Daigo Nagahara, Tomoaki Nakata, Akiyoshi Hashimoto et al. · Journal of Nuclear Medicine · 2008 · 141 citations · Full text

Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako-tsubo cardiomyopathy)

Takuji Yoshioka, Akiyoshi Hashimoto, Kazufumi Tsuchihashi et al. · American Heart Journal · 2008 · 122 citations

Cardiomyopathy, Heart Failure, Clinical Implications +11

Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure

Tomoaki Nakata, Takeru Wakabayashi, Michifumi Kyuma et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2004 · 61 citations

Hypertension, Heart Failure, Cardiovascular Disease +10